Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials.

Wu Y, Guo X, Li R, Le Corre C.

DOI: 10.1002/pst.70123
Published: 2026-09-01
Container: Pharm Stat
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/pst.70123,
  title = {Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials.},
  author = {Wu Y and  Guo X and  Li R and  Le Corre C.},
  year = {2026},
  journal = {Pharm Stat},
  doi = {10.1002/pst.70123},
  url = {https://doi.org/10.1002/pst.70123}
}

RIS

TY  - JOUR
TI  - Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials.
AU  - Wu Y
AU  -  Guo X
AU  -  Li R
AU  -  Le Corre C.
PY  - 2026
JO  - Pharm Stat
DO  - 10.1002/pst.70123
UR  - https://doi.org/10.1002/pst.70123
ER  -

APA

Y, W., X, G., R, L., & C., L. C. (2026). Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials.. Pharm Stat. https://doi.org/10.1002/pst.70123

Source records

europe-pmc · retrieved 2026-09-26T07:32:51.396Z